Department of Immunopathology, SA Pathology at the Women's and Children's Hospital, North Adelaide, SA 5006, Australia.
Adelaide School of Medicine and the Robinson Research Institute, University of Adelaide, Adelaide, SA 5005, Australia.
Int J Mol Sci. 2021 Nov 23;22(23):12650. doi: 10.3390/ijms222312650.
Cord blood T cells (CBTC) from a proportion of newborns express low/deficient levels of some protein kinase C (PKC) isozymes, with low levels of PKCζ correlating with increased risk of developing allergy and associated decrease in interferon-gamma (IFN-γ) producing T cells. Interestingly, these lower levels of PKCζ were increased/normalized by supplementing women during pregnancy with n-3 polyunsaturated fatty acids. However, at present, we have little understanding of the transient nature of the deficiency in the neonate and how PKCζ relates to other PKC isozymes and whether their levels influence maturation into IFN-γ producing T cells. There is also no information on PKCζ isozyme levels in the T cell subpopulations, CD4 and CD8 cells. These issues were addressed in the present study using a classical culture model of neonatal T cell maturation, initiated with phytohaemagglutinin (PHA) and recombinant human interleukin-2 (rhIL-2). Of the isozymes evaluated, PKCζ, β2, δ, μ, ε, θ and λ/ι were low in CBTCs. The PKC isozyme deficiencies were also found in the CD4 and CD8 T cell subset levels of the PKC isozymes correlated between the two subpopulations. Examination of changes in the PKC isozymes in these deficient cells following addition of maturation signals showed a significant increase in expression within the first few hours for PKCζ, β2 and μ, and 1-2 days for PKCδ, ε, θ and λ/ι. Only CBTC PKCζ isozyme levels correlated with cytokine production, with a positive correlation with IFN-γ, interleukin (IL)-2 and tumour necrosis factor-alpha (TNF), and a negative association with IL-9 and IL-10. The findings reinforce the specificity in using CBTC PKCζ levels as a biomarker for risk of allergy development and identify a period in which this can be potentially 'corrected' after birth.
脐带血 T 细胞(CBTC)中,一部分新生儿的某些蛋白激酶 C(PKC)同工酶表达水平较低/缺乏,PKCζ 水平较低与过敏风险增加以及相关的干扰素-γ(IFN-γ)产生 T 细胞减少有关。有趣的是,在怀孕期间用 n-3 多不饱和脂肪酸补充孕妇可增加/使 CBTC 中的 PKCζ 水平正常化。然而,目前我们对新生儿中这种 PKCζ 缺乏的短暂性质以及 PKCζ 与其他 PKC 同工酶的关系,以及它们的水平是否影响成熟为 IFN-γ产生 T 细胞知之甚少。也没有关于 CBTC 中 T 细胞亚群(CD4 和 CD8 细胞)中 PKCζ 同工酶水平的信息。本研究使用经典的新生儿 T 细胞成熟培养模型解决了这些问题,该模型以植物血球凝集素(PHA)和重组人白细胞介素-2(rhIL-2)启动。在所评估的同工酶中,CBTC 中的 PKCζ、β2、δ、μ、ε、θ和 λ/ι 水平较低。在 CD4 和 CD8 T 细胞亚群中也发现了 PKC 同工酶的缺乏,并且在两个亚群之间存在相关性。在添加成熟信号后,观察这些缺乏细胞中 PKC 同工酶的变化,发现 PKCζ、β2 和 μ 的表达在最初几个小时内显著增加,PKCδ、ε、θ 和 λ/ι 的表达在 1-2 天内增加。只有 CBTC PKCζ 同工酶水平与细胞因子产生相关,与 IFN-γ、白细胞介素(IL)-2 和肿瘤坏死因子-α(TNF)呈正相关,与 IL-9 和 IL-10 呈负相关。这些发现强化了使用 CBTC PKCζ 水平作为过敏发展风险的生物标志物的特异性,并确定了出生后潜在的“纠正”期。